Professor Andrew Forbes has an international reputation for leadership in biostatistics, stemming from his development and innovation in statistical methods to solve practical issues in health and medical research studies, as well as collaboration on major practice-changing research in substantive clinical areas. He chairs the pre-eminent multi-university national training program in biostatistics and has major roles with the Australian Clinical Trials Alliance (ACTA) in promulgating innovative clinical trial design methodologies.

Professor Forbes heads the nation’s largest biostatistics group and for over a decade has been an Editorial Board member of one of the leading international journals, Statistical Methods in Medical Research.